Medicine and Dentistry
Osteolysis
100%
Placebo
84%
Semaglutide
84%
Stem Cell
84%
Ossification
58%
Cellular Senescence
56%
Procollagen
38%
Amino Terminal Sequence
38%
Bone Fragility
28%
Hip
23%
Lumbar Spine
23%
Bone Density
15%
Investigational Drug
7%
Femoral Neck
7%
C-Terminal Telopeptide
7%
Body Weight
7%
Glucagon-Like Peptide-1 Agonist
7%
Postmenopause
7%
Hypoglycemia
7%
Body Mass Index
7%
Adverse Event
7%
Clinical Trial
7%
Collagen Type 1
7%
Pharmacology, Toxicology and Pharmaceutical Science
Semaglutide
84%
Placebo
84%
Procollagen
38%
Telopeptide
7%
Collagen Type 1
7%
Hypoglycemia
7%
Glucagon Like Peptide 1 Receptor Agonist
7%
Clinical Trial
7%
Adverse Event
7%
Investigational Drug
7%